Switzerland (CH)

Epitope-focused immunogens targeting the hepatitis C virus glycoproteins induce broadly neutralizing antibodies (2024) Nagarathinam K, Scheck A, Labuhn M, Ströh LJ, Herold E, Veselkova B, Tune S, et al. Journal article Data-driven modelling of hydraulic-head time series: results and lessons learned from the 2022 Groundwater Time Series Modelling Challenge (2024) Collenteur RA, Haaf E, Bakker M, Liesch T, Wunsch A, Soonthornrangsan J, White J, et al. Journal article Endemic-epidemic modelling of school closure to prevent spread of COVID-19 in Switzerland (2024) Bekker-Nielsen Dunbar M, Hofmann F, Meyer S, Held L Journal article Immunogenetics of lithium response and psychiatric phenotypes in patients with bipolar disorder (2024) Herrera-Rivero M, Gutiérrez-Fragoso K, Kurtz J, Baune BT, Thalamuthu A, Amare AT, Adli M, et al. Journal article Exploring the genetics of lithium response in bipolar disorders (2024) Herrera-Rivero M, Adli M, Akiyama K, Akula N, Amare AT, Ardau R, Arias B, et al. Journal article Lithium response in bipolar disorder is associated with focal adhesion and PI3K-Akt networks: a multi-omics replication study (2024) Ou AH, Rosenthal SB, Adli M, Akiyama K, Akula N, Alda M, Amare AT, et al. Journal article Correspondence to “Bipolar disorder-iPSC derived neural progenitor cells exhibit dysregulation of store-operated Ca2+ entry and accelerated differentiation” by Hewitt et al. (PMID: 37402854) (2024) Yde Ohki CM, McNeill RV, Vernon AC, Smedler E, Michel TM, Peitz M, Potier MC, et al. Journal article Towards Establishing Best Practice in the Analysis of Hydrogen and Deuterium by Atom Probe Tomography (2024) Gault B, Saksena A, Sauvage X, Bagot P, Aota LS, Arlt J, Belkacemi LT, et al. Journal article, Review article Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial (2024) Harbeck N, Ciruelos E, Jerusalem G, Müller V, Niikura N, Viale G, Bartsch R, et al. Journal article Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy (2024) Merz M, Dima D, Hashmi H, Ahmed N, Stölzel F, Holderried TA, Fenk R, et al. Journal article